Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease
- 1 March 2000
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 42 (3), 480-489
- https://doi.org/10.1016/s0190-9622(00)90223-8
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Role of lymphatic mapping and sentinel node biopsy in melanoma detectionEuropean Journal Of Cancer, 1998
- Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysisCancer, 1993
- A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanomaCancer, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Neck dissection for cutaneous malignant melanomaWorld Journal of Surgery, 1992
- The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanomaCancer, 1989
- A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous MelanomaNew England Journal of Medicine, 1982
- A Randomized Trial of Levamisole versus Placebo as Adjuvant Therapy in Malignant MelanomaNew England Journal of Medicine, 1980
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsNew England Journal of Medicine, 1977
- The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasisEuropean Journal of Cancer (1965), 1973